Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature

Related Research units

Bibliographical data

Original languageGerman
Article number1
Publication statusPublished - 2012